These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9116049)

  • 1. DNA modifying agents as tools for studying chromatin structure.
    Millard JT
    Biochimie; 1996; 78(10):803-16. PubMed ID: 9116049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin as a target for the DNA-binding anticancer drugs.
    Majumder P; Pradhan SK; Devi PG; Pal S; Dasgupta D
    Subcell Biochem; 2007; 41():145-89. PubMed ID: 17484128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of bulky chemical carcinogens with DNA in chromatin.
    MacLeod MC
    Carcinogenesis; 1995 Sep; 16(9):2009-14. PubMed ID: 7554047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of a DNA-threading netropsin-amsacrine combilexin with DNA and chromatin.
    Bourdouxhe-Housiaux C; Colson P; Houssier C; Waring MJ; Bailly C
    Biochemistry; 1996 Apr; 35(14):4251-64. PubMed ID: 8605173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineoplastic DNA-binding compounds: intercalating and minor groove binding drugs.
    Mišković K; Bujak M; Baus Lončar M; Glavaš-Obrovac L
    Arh Hig Rada Toksikol; 2013 Dec; 64(4):593-602. PubMed ID: 24384766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The search of DNA-intercalators as antitumoral drugs: what it worked and what did not work.
    Martínez R; Chacón-García L
    Curr Med Chem; 2005; 12(2):127-51. PubMed ID: 15638732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intercalation of small molecules into DNA in chromatin is primarily controlled by superhelical constraint.
    Bosire R; Nánási P; Imre L; Dienes B; Szöőr Á; Mázló A; Kovács A; Seidel R; Vámosi G; Szabó G
    PLoS One; 2019; 14(11):e0224936. PubMed ID: 31747397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of an intercalating antitumoral agent: 9-hydroxy-2-methyl ellipticinium (NMHE) with chromatin.
    Larue L; Quesne M; Paoletti J
    Biochem Pharmacol; 1987 Nov; 36(21):3563-9. PubMed ID: 3675613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specifically modified oligodeoxynucleotides as probes for the structural and biological effects of DNA-damaging agents.
    Basu AK; Essigmann JM
    Chem Res Toxicol; 1988; 1(1):1-18. PubMed ID: 2979705
    [No Abstract]   [Full Text] [Related]  

  • 10. Caffeine and other xanthines as cytochemical blockers and removers of heterocyclic DNA intercalators from chromatin.
    Lyles MB; Cameron IL
    Cell Biol Int; 2002; 26(2):145-54. PubMed ID: 11846444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding.
    Bachur NR; Johnson R; Yu F; Hickey R; Applegren N; Malkas L
    Mol Pharmacol; 1993 Nov; 44(5):1064-9. PubMed ID: 8246909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-DNA sequence-dependent interactions analysed by electric linear dichroism.
    Bailly C; Hénichart JP; Colson P; Houssier C
    J Mol Recognit; 1992 Dec; 5(4):155-71. PubMed ID: 1339484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A revisit of the mode of interaction of small transcription inhibitors with genomic DNA.
    Dasgupta D; Majumder P; Banerjee A
    J Biosci; 2012 Jul; 37(3):475-81. PubMed ID: 22750984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-directed alkylating ligands as potential antitumor agents: sequence specificity of alkylation by intercalating aniline mustards.
    Prakash AS; Denny WA; Gourdie TA; Valu KK; Woodgate PD; Wakelin LP
    Biochemistry; 1990 Oct; 29(42):9799-807. PubMed ID: 2271617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naphthalimide intercalators with chiral amino side chains: effects of chirality on DNA binding, photodamage and antitumor cytotoxicity.
    Yang Q; Yang P; Qian X; Tong L
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6210-3. PubMed ID: 18930399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of DNA-binding drugs on chromatin condensation.
    Sen D; Crothers DM
    Biochemistry; 1986 Apr; 25(7):1503-9. PubMed ID: 2423111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mutagenic properties of DNA minor-groove binding ligands.
    Turner PR; Denny WA
    Mutat Res; 1996 Aug; 355(1-2):141-69. PubMed ID: 8781582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Specificity of the interaction of carcinogenic and cytostatic agents with the elements of the genome at different levels of its organization].
    S'iakste NI; S'iakste TG
    Eksp Onkol; 1988; 10(2):3-8. PubMed ID: 3292213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential scanning calorimetry of nuclei as a test for the effects of anticancer drugs on human chromatin.
    Almagor M; Cole RD
    Cancer Res; 1989 Oct; 49(20):5561-6. PubMed ID: 2477145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid alters chromatin structure by regulation of chromatin modulation proteins.
    Marchion DC; Bicaku E; Daud AI; Sullivan DM; Munster PN
    Cancer Res; 2005 May; 65(9):3815-22. PubMed ID: 15867379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.